Ocean Bio Chem Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Ocean Bio Chem Inc (OBCI) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Ocean Bio Chem Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 63M vs 35,789M combined for tracked competitors (0.2% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-4.1% annualized vs trailing 12 months), vs accelerating (+30.3%) for its tracked peer group.
- Growth: Ocean Bio Chem Inc generated -3.1% revenue growth year over year in Q2 2022, vs -1.0% for its tracked competitors combined.
- Profitability: Its -2.1% net margin compares with 2.4% for the peer group.
- Peer revenue share: Ocean Bio Chem Inc accounted for 0.1% of combined revenue among its tracked peer group, up from 0.1% a year earlier.
- Peer differentiation: Revenue per employee of $0.50M compares with $0.46M for the peer group (1.1x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
OBCI Sales vs. its Competitors, Q2 2022
Ocean Bio Chem Inc reported revenue contraction of 3.06 % year on year in Q2 2022, below its competitors' combined revenue change of -1.04 %.
With a net margin of -2.11 %, Ocean Bio Chem Inc reported lower profitability than its competitors (2.44 %).
Ocean Bio Chem Inc generated 0.13 % of the combined sales of its peer group, up from 0.13 % a year earlier.
Ocean Bio Chem Inc vs. its Competitors, Q2 2022
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Ocean Bio Chem Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Ocean Bio chem Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (8) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Ocean Bio Chem Inc's competitor groups requires a Commercial License.
For context: the Personal & Household Products industry grew revenue -4.6% year over year, combined, vs -3.1% for Ocean Bio Chem Inc. Ocean Bio Chem Inc's share of combined industry revenue moved from 0.01% to 0.01%, a gain of 0.00 percentage points.
Ocean Bio Chem Inc's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Ocean Bio chem Inc | Yes | Yes | Yes | Yes |
| Competitors combined (6) | ||||
| Similar Growth & Profitability (8) | 87.50 % (7 of 8) | 87.50 % (7 of 8) | 75.00 % (6 of 8) | 0.00 % (0 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
OBCI Stock Performance relative to its Competitors
OBCI Stock Performance relative to Similar Growth & Profitability Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Ashland Inc | 282.9% | Outperformed |
| 2 | Innospec Inc | 282.9% | Outperformed |
| 3 | 3m Company | 282.9% | Outperformed |
| 4 | 374water Inc | 282.9% | Outperformed |
| 5 | Nl Industries inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Ocean Bio Chem Inc's best-performing tracked competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Ocean Bio Chem Inc's Comment on Competition and Industry Peers
Competition with respect to our principal product lines is described below.
The principal elements of competition affecting all of our product lines are
brand recognition, price, service and the ability to deliver products on a timely
basis.
Marine: We have several national and regional competitors in the marine marketplace.
We do not believe that any competitor or small group of competitors hold a dominant
market share. We believe that we can increase or maintain our market share through
expenditures directed to our present advertising and distribution channels.
Automotive: There are a large number of companies, both national and regional,
that compete with us. Many are more established and have greater financial resources
than we do. While our market share is small, the total market size is substantial.
We believe that we have established a reasonable market share through our present
advertising and distribution channels, considering the large size of this market.
Recreational Vehicle/Power Sports: We compete with national and regional competitors.
We do not believe that any competitor or small group of competitors hold a dominant
market share. We believe that we can increase or maintain our market share by
utilizing similar advertising and distribution channels to those we use in the
marine market.
Outdoor Power Equipment/Lawn & Garden: We compete with several established
national and regional competitors. We do not believe that any competitor or
small group of competitors hold a dominant market share. We have attempted to
make inroads in this market by emphasizing Star Tron®’s unique formulation
and by increasing our advertising and attendance at trade shows.
Disinfectants, Sanitizers and Deodorants: There are a large number of companies
that compete with us, many of which are much larger, and have much greater financial
resources than we do. We emphasize the effectiveness of chlorine dioxide, coupled
with the convenience in application of our Performacide® products.
Publicly Traded Peers of Ocean Bio chem Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
| Ocean Bio chem Inc | 123.91 | 63.42 |
| 3m Company | 88,536.35 | 25,180.00 |
| The Clorox Company | 9,915.90 | 6,760.00 |
| Ashland Inc | 3,131.22 | 1,842.00 |
| Innospec Inc | 2,418.32 | 1,842.10 |
| Nl Industries inc | 342.17 | 161.83 |
| SUBTOTAL | 104,519.64 | 35,852.87 |
Sign in to see all competitors of Ocean Bio chem Inc.
Sources: Ocean Bio chem Inc's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Ocean Bio chem Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Ocean Bio Chem Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| 3m Company | Safety and Industrial 47.55 % |
| Ashland Inc | Life Sciences 36.22 % |
| Innospec Inc | Refinery and Performance 28.88 % |
| Nl Industries inc | Security Products 73.69 % |
Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Ocean Bio Chem Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Ocean Bio chem Inc | 124 | 495,504 | 38,096 |
| 3m Company | 88,536 | 416,198 | 49,785 |
| The Clorox Company | 9,916 | 768,182 | 87,500 |
| Ashland Inc | 3,131 | 635,172 | 17,586 |
| Innospec Inc | 2,418 | 751,878 | 49,918 |
| Nl Industries inc | 342 | 57,550 | -20,655 |
| PEERS TOTAL | 104,396 | 461,740 | 50,023 |
Ocean Bio Chem Inc's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent filing. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| 3m Company | Americas 54.09 % |
Source: revenue geography as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Ocean Bio Chem Inc's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Personal & Household Products industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (41 companies).| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 34.26 % | 48.81 % (avg) | -14.6 pp |
| Operating Margin | 10.03 % | industry median | +10.6 pp |
| EBITDA Margin | 12.35 % | 5.40 % (avg) | +7.0 pp |
| Capital Intensity (Capex / Revenue) | 11.33 % | 2.23 % (avg) | +9.1 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Ocean Bio Chem Inc's Valuation vs Competitive Position
Valuation multiples vs the Personal & Household Products industry average (41 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | 18.4x | 29.0x | -10.7x |
| EV / EBITDA | 11.4x | 19.3x | -7.9x |
| P/B | 1.9x | 4.2x | -2.3x |
| Return on Equity | 10.24 % | industry aggregate | -20.97 % |
| Return on Invested Capital | 6.15 % | 12.14 % (avg) | -5.99 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Ocean Bio Chem Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in SEC filings.| Metric | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|---|
| Revenue Growth | 15.66 % | 0.18 % | 6.53 % | 7.53 % | 7.36 % | 1.10 % | 31.48 % | 15.73 % |
| Operating Margin | 8.91 % | 2.21 % | 8.55 % | 9.44 % | 8.87 % | 10.92 % | 21.89 % | 16.89 % |
| Return on Invested Capital | 7.67 % | 1.81 % | 7.29 % | 7.31 % | 6.45 % | 7.26 % | 15.80 % | 11.29 % |
| P/E | - | - | 16.2x | 15.5x | 11.4x | 9.2x | 13.2x | 10.5x |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Ocean Bio Chem Inc's Strategic Group Map
Every company in Ocean Bio Chem Inc's industry and named-competitor list, plotted by trailing 12-month revenue growth and operating margin. Ocean Bio Chem Inc is shown in red; its closest peers by combined growth, margin and ROIC (the Similar Growth & Profitability group above) are labeled.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
Ocean Bio Chem Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Barriers to Entry | High (capital intensive) | Capital intensity (capex / revenue) of 11.33 % vs industry average 2.23 % (see Profitability & Cost Structure above) |
| Supplier Power | Not covered on this page | See Ocean Bio Chem Inc's dedicated suppliers page for concentration and dependency data |
| Buyer Power | Not covered on this page | See Ocean Bio Chem Inc's dedicated customers page for concentration and dependency data |
| Threat of Substitutes | - | No systematic data source for cross-product substitution exists in this system; not estimated |
Note: this is a partial, data-grounded application of the framework, not a complete strategic assessment. Rivalry and barriers-to-entry readings are mechanical translations of the HHI and capital-intensity figures shown elsewhere on this page, not independent judgments.
Ocean Bio Chem Inc's Industry Attractiveness & Competitive Strength
A CSIMarket composite, not a standard field: each axis is an equal-weighted average of three factors already shown elsewhere on this page (industry growth, industry profitability and rivalry for attractiveness; relative market share, profitability and growth vs industry for strength). Disclosed as a designed methodology, not a precision measurement.
Ocean Bio Chem Inc falls in the Low attractiveness / High strength cell: Selective.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Ocean Bio Chem Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
- Operating margin 10.6 points above the industry median.
Weaknesses
- Return on equity 21.0 points below the industry aggregate.
- Latest-quarter revenue run-rate is decelerating (-4.1% annualized vs trailing 12 months).
- Piotroski F-Score of 2 or below, the standard financial-distress signal.
Opportunities
No rule matched.
Threats
- High capital intensity requires continuous reinvestment just to keep pace with the industry.
Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.
Ocean Bio Chem Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Ocean Bio chem Inc | 1.48 | 6.47 | 0.18 |
| 3m Company | - | 1.57 | 3.20 |
| The Clorox Company | 0.18 | 0.82 | 9.85 |
| Ashland Inc | 0.76 | 2.95 | 0.73 |
| Innospec Inc | 0.78 | 2.83 | - |
| Nl Industries inc | 5.11 | 7.39 | - |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Ocean Bio Chem Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Ocean Bio chem Inc | Q2 2022 | -3.1 % | - |
| 3m Company | Q2 2026 | +2.5 % | +29.4 % |
| The Clorox Company | Q1 2026 | +0.1 % | +0.0 % |
| Ashland Inc | Q2 2026 | +7.3 % | - |
| Innospec Inc | Q2 2026 | +11.8 % | +32.8 % |
| Nl Industries inc | Q2 2026 | +8.0 % | +838.4 % |
| PEERS TOTAL | +2.8 % | +501.8 % |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Ocean Bio Chem Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Ocean Bio chem Inc | Q2 2022 | +17.1 % | -47.5 % |
| 3m Company | Q2 2026 | +4.7 % | +7.2 % |
| The Clorox Company | Q1 2026 | +2.6 % | - |
| Ashland Inc | Q2 2026 | -1.2 % | +0.0 % |
| Innospec Inc | Q2 2026 | +11.6 % | +6.6 % |
| Nl Industries inc | Q2 2026 | +2.2 % | -16.8 % |
Ocean Bio Chem Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Ocean Bio chem Inc | 7.79% | 8.73% | 10.24% |
| 3m Company | 8.27% | 11.16% | 76.55% |
| The Clorox Company | 13.34% | 19.55% | 257.96% |
| Ashland Inc | 1.11% | 1.29% | 2.70% |
| Innospec Inc | 6.70% | 8.28% | 9.16% |
| Nl Industries inc | - | - | - |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Ocean Bio Chem Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Ocean Bio chem Inc | 25.07 | 1.95 |
| 3m Company | 30.10 | 3.52 |
| The Clorox Company | 13.24 | 1.47 |
| Ashland Inc | 61.88 | 1.70 |
| Innospec Inc | 20.18 | 1.31 |
| Nl Industries inc | - | 2.11 |
| PEERS AVERAGE | 26.92 | 2.92 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.